Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | AMGN | GILD | CELG | VRTX |
| Company | Catabasis Pharma | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 9.21 | 273.45 | 67.47 | 108.01 | 402.44 |
| High | 9.21 | 274.35 | 67.90 | 108.59 | 403.88 |
| Low | 8.46 | 268.65 | 66.02 | 107.27 | 395.12 |
| Last | 8.54 | 268.22 | 65.75 | 108.24 | 395.09 |
| Change | -0.64 | -4.79 | -1.33 | +0.11 | -5.67 |
| % Change | -6.97% | -1.75% | -1.98% | +0.10% | -1.41% |
| Volume | 98,800 | 211,378 | 1,265,755 | 191,230,496 | 101,042 |
| 20-Day Average Volume | 395,311 | 2,067,326 | 6,147,293 | 16,188,930 | 928,609 |
| Previous Close | 9.18 | 273.01 | 67.08 | 108.13 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 270.76 | 68.74 | 108.17 | 402.33 |
| 20-Day Raw Stochastic | 56.46% | 35.18% | 6.90% | 63.25% | 23.16% |
| 20-Day Relative Strength | 43.24% | 45.78% | 31.27% | 64.69% | 42.93% |
| Weighted Alpha | -50.43 | +9.74 | -21.80 | +46.30 | +15.01 |
| Today's Opinion | 88% Sell | 72% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 72% Sell | 40% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Sell | 24% Buy | 88% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | +2.95% since 04/18/24 | +0.44% since 04/18/24 | -1.97% since 11/13/19 | +1.16% since 04/18/24 |
| Low | 8.46 on 09/08/21 | 260.68 on 04/19/24 | 66.16 on 04/19/24 | 107.27 on 11/20/19 | 391.25 on 04/19/24 |
| High | 10.26 on 09/02/21 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | -3.68% since 03/25/24 | -8.45% since 03/25/24 | +5.14% since 10/18/19 | -4.32% since 03/25/24 |
| Low | 6.31 on 08/20/21 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 10.26 on 09/02/21 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | -12.82% since 01/25/24 | -17.18% since 01/25/24 | +13.63% since 08/20/19 | -7.42% since 01/25/24 |
| Low | 6.31 on 08/20/21 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 15.72 on 06/16/21 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | -0.61% since 10/25/23 | -15.23% since 10/25/23 | +14.14% since 05/20/19 | +9.65% since 10/25/23 |
| Low | 6.31 on 08/20/21 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 22.01 on 03/18/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 146,436,016 | 83,519,768 | 77,035,920 | 103,580,040 |
| Shares Outstanding, K | 3,904 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -37,300,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -7,470,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.66 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 08/09/21 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 10.99 | 30.13 |